Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on May 27, 2026

May 27, 2026

Korro to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 27, 2026

BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

May 27, 2026

X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 27, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Indeterminate GlobeNewswire

May 27, 2026

Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South

Indeterminate GlobeNewswire

May 27, 2026

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 27, 2026

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

Indeterminate GlobeNewswire

May 27, 2026

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

May 27, 2026

World’s First Class III Approval for a Breakthrough Medical Imaging AI: Diagens AI AutoVision®

Indeterminate GlobeNewswire

May 27, 2026

Apogee Therapeutics Announces $1.3 Billion Strategic Financing Collaboration with Blackstone Life Sciences to Advance Phase 3 Development and Commercialization of Zumilokibart

Indeterminate GlobeNewswire

May 27, 2026

Apogee Therapeutics Announces Positive 16-Week Part B Induction Dose Optimization Results from Phase 2 APEX Trial of Zumilokibart in Moderate-to-Severe Atopic Dermatitis

Indeterminate GlobeNewswire

May 27, 2026

InnoCare Announces Approval of Orelabrutinib in Australia

Indeterminate GlobeNewswire

May 27, 2026

AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026

Indeterminate GlobeNewswire

May 27, 2026

Youth Vaping at Historic Lows: Why Vaping Is Canada's Path to a Smoke-Free Future

Indeterminate GlobeNewswire

May 27, 2026

Agomab Announces Results of Annual General Meeting

Indeterminate GlobeNewswire

May 27, 2026

LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children

Indeterminate GlobeNewswire

May 27, 2026

Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics

Indeterminate GlobeNewswire

May 27, 2026

Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions

Indeterminate GlobeNewswire

May 27, 2026

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Indeterminate GlobeNewswire

May 27, 2026

Intravacc erhält Genehmigung der französischen CIR zur Unterstützung von Partnerschaften in der Impfstoffforschung und -entwicklung

Indeterminate GlobeNewswire